NLS-T

NLS-T is an experimental **nucleopeptide-based antitumor construct** described as a comparator or precursor to the more active transformable nucleopeptide nanoparticle NLS-FF-T in preclinical bladder cancer research. Based on the reported study, NLS-T appears to be a **nuclear localization sequence-containing nucleopeptide** designed within an intracellular ATP sequestration platform, but it lacks the full transformable nanofibrous ATP-trapping behavior and antitumor potency reported for NLS-FF-T. The available evidence supports NLS-T as a **research-stage nanomaterial/peptide therapeutic candidate** evaluated in bladder cancer cell models rather than a clinically developed pharmaceutical product, and publicly available source text does not clearly define a commercial developer, manufacturer, or fully resolved molecular identity.

Other names

transformable nucleopeptidenucleopeptide precursor